BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AFSSI Sciences de la Vie - ECPv5.14.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:AFSSI Sciences de la Vie
X-ORIGINAL-URL:https://www.afssi.fr
X-WR-CALDESC:Events for AFSSI Sciences de la Vie
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20180325T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20181028T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180930
DTEND;VALUE=DATE:20181004
DTSTAMP:20260526T042054
CREATED:20180525T095454Z
LAST-MODIFIED:20181003T123335Z
UID:7311-1538265600-1538611199@www.afssi.fr
SUMMARY:9th Santorini Conference
DESCRIPTION:The Santorini Conference Series have been founded in 2000 on the initiative of Professor Gerard Siest (┼\, INSERM UMR U1122; IGE-PCV\, University of Lorraine\, Nancy\, France\,in memory of Gerard Siest) and several representatives of industrial companies with the intention to create an independent and open platform to mediate “translation” in personalised medicine. \nWith a Steering Committee (SC) and a Scientific Advisory Board (SAB) with members across academia\, clinics and industry\, the 9th Santorini Conference aims to facilitate scientific exchange between basic research\, industrial research and medical areas. The conference has been maintained and strengthened by a sustainable and clearly visible new concept with respect to content\, structure\, economy and people. \nThe title is dealing with Greek mythology in the spirit of the island and of thematic obstacles to resolve and overcome: \nSystems Medicine\, Personalised Health & Therapy. “The Odyssey from Hope to Practice” with a special focus on “cardio-metabolic diseases and cancer”. \n  \nThe scientific programme also includes 1 session with young researchers’ lectures. The 2 best posters will be granted with “Gerard Siest” awards. \nThe 9th Conference aims to answer: \n\nCan genetic screening help identify individuals at greatest risk for cardio-metabolic diseases and cancer?\nWhat is the greatest clinical need with regard to diagnosis\, prediction and patient stratification for these pathologies and how this is/can be addressed?\nDoes a genetic risk score identify patients at highest risk and is its use justified in clinical practice?\nWhat are the challenges of the current clinical trials?\nWhat about comorbidities with aging?\nWhat is the impact of pharmacogenomics on:\nDeliverance of more predictable responses to drug therapy\nMinimisation of the occurrence and severity of adverse drug reactions\nConduction of more cost-effective clinical trials\nDrug discovery and the drug development process\nDo the existing diagnostic tools answer the needs of pharmacogenomics?
URL:https://www.afssi.fr/event/9th-santorini-conference/
LOCATION:Petros M. Nomikos Conference Centre\, Santorini\, Grèce
CATEGORIES:Evénement filière
ATTACH;FMTTYPE=image/jpeg:https://www.afssi.fr/wp-content/uploads/2018/05/event-santorini_conference_2018-1.jpg
END:VEVENT
END:VCALENDAR